TerminatedPhase 1NCT02706392

Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fred Hutchinson Cancer Center
Principal Investigator
David Maloney
Fred Hutch/University of Washington Cancer Consortium
Intervention
Laboratory Biomarker Analysis(other)
Enrollment
21 enrolled
Eligibility
18 years · All sexes
Timeline
20162021

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02706392 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials